PARP1 and atrial fibrillation: Research suggests that the pathological cycle mediated by PARP1 activation and NAD+ depletion plays a crucial role in maintaining genome integrity and cardiomyocyte function and serves as a significant regulatory mechanism for aging-related AF [64].